The role of 18F-FDG PET/CT in evaluation of early response to neoadjuvant chemotherapy in patients with locally advanced breast cancer. - Wikidata - wikimedia - TriplyDB

The role of 18F-FDG PET/CT in evaluation of early response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.

The role of 18F-FDG PET/CT in evaluation of early response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.

http://www.wikidata.org/entity/Q46123246

about

Role of Positron Emission Tomography-Computed Tomography in Locally Advanced Breast Cancer Role of positron emission tomography for the monitoring of response to therapy in breast cancer Usefulness of Combined Metabolic-Volumetric Indices of (18)F-FDG PET/CT for the Early Prediction of Neoadjuvant Chemotherapy Outcomes in Breast Cancer.Monitoring tumor response to neoadjuvant chemotherapy using MRI and 18F-FDG PET/CT in breast cancer subtypes Utility of FDG-PET/CT in the evaluation of the response of locally advanced breast cancer to neoadjuvant chemotherapy The role of chemotherapeutic drugs in the evaluation of breast tumour response to chemotherapy using serial FDG-PET Early metabolic response using FDG PET/CT and molecular phenotypes of breast cancer treated with neoadjuvant chemotherapy.Association between serial dynamic contrast-enhanced MRI and dynamic 18F-FDG PET measures in patients undergoing neoadjuvant chemotherapy for locally advanced breast cancer.Metabolic positron emission tomography imaging in cancer detection and therapy response.Breast conservation in locally advanced breast cancer.Comparison of PET metabolic indices for the early assessment of tumour response in metastatic colorectal cancer patients treated by polychemotherapy.Comparison of the diagnostic performance of response evaluation criteria in solid tumor 1.0 with response evaluation criteria in solid tumor 1.1 on MRI in advanced breast cancer response evaluation to neoadjuvant chemotherapy.Dynamic contrast-enhanced MR imaging in a phase Ⅱ study on neoadjuvant chemotherapy combining Rh-endostatin with docetaxel and epirubicin for locally advanced breast cancer Value of volume-based metabolic parameters for predicting survival in breast cancer patients treated with neoadjuvant chemotherapy.A molecular imaging primer: modalities, imaging agents, and applications.Diagnostic and prognostic application of positron emission tomography in breast imaging: emerging uses and the role of PET in monitoring treatment response.Present and future role of FDG-PET/CT imaging in the management of breast cancer.¹⁸F-FDG PET/CT in the early prediction of pathological response in aggressive subtypes of breast cancer: review of the literature and recommendations for use in clinical trials.18F-FDG PET/CT as an Indicator of Survival in Ewing Sarcoma of Bone.Molecular imaging in oncology: the acceptance of PET/CT and the emergence of MR/PET imaging.Circulating procalcitonin in aseptic carcinoma patients: a specificity study with (18)F-fluorodeoxyglucose positron-emission tomography/computed tomography as benchmark.¹⁸F-FDG PET SUVmax as an indicator of histopathologic response after neoadjuvant chemotherapy in extremity osteosarcoma.Evaluation of tumor stiffness by elastography is predictive for pathologic complete response to neoadjuvant chemotherapy in patients with breast cancer.Imaging Considerations and Interprofessional Opportunities in the Care of Breast Cancer Patients in the Neoadjuvant Setting.FDG-PET/CT for the early prediction of histopathological complete response to neoadjuvant chemotherapy in breast cancer patients: initial results.Is 18F-FDG PET accurate to predict neoadjuvant therapy response in breast cancer? A meta-analysis.Quantitative assessment of tumor blood flow changes in a murine breast cancer model after adriamycin chemotherapy using contrast-enhanced destruction-replenishment sonography.Changes in (18)F-fluorothymidine and (18)F-fluorodeoxyglucose positron emission tomography imaging in patients with head and neck cancer treated with chemoradiotherapy.Predictive value of neoadjuvant chemotherapy failure in breast cancer using FDG-PET after the first course.FDG PET evaluation of early axillary lymph node response to neoadjuvant chemotherapy in stage II and III breast cancer patients.Early monitoring of response to neoadjuvant chemotherapy in breast cancer with 18F-FDG PET/CT: defining a clinical aim.

P2860

Q28079818-4D929EB1-3BEA-43E2-9469-95ABC7E2FF51 Q28080621-AB05EE0D-EF74-46BF-A02A-FE1A1B1276FD Q33670107-3C2D01D5-AD75-418A-BBD1-4F420DB2F837 Q33712925-BE986A17-92F6-46C0-BCA7-E7BE3D958D31 Q33966252-D67CBF44-BE1B-4D5E-94CB-7AC13D297F95 Q34048123-0C5A8623-71E3-44A4-89F7-9403400FCBF6 Q34051790-0B2C7FB3-A051-4DEA-9328-E4C799ABAC20 Q34257646-F4A4C6FA-1F4E-42C9-9DCB-1CCCEE7A1851 Q34786518-7198812B-FA60-44E0-88FF-CFE3829384FE Q36169992-B37FCA6A-DC1A-46C8-9484-5C330696FB6B Q36508524-CAE56E08-9856-420A-A6A3-6D437B3E77A7 Q36524335-C772B4E9-A1C1-4079-8F2E-CC3AB7BB3136 Q36540092-183083EC-C17B-4CA3-B01D-36F5EE32E209 Q37354718-C08CBF8E-F0DA-4445-891D-70232534C45A Q38005672-8B0640B2-12B7-45F2-BB60-155DCBD08B38 Q38090509-D3A88928-1021-4369-A295-FC90661F7603 Q38687620-D22A55B6-D225-4575-A03F-1ACF9530CF2C Q38693888-15721613-C229-40C7-8559-E9206897884B Q41721716-01E735B4-216F-4D5B-B767-AB77DDED4885 Q42587608-84C62759-7136-4902-A002-D3762012109E Q43074699-DFCDCD42-FC91-4AA5-B3B1-8E27D43FF63A Q44090756-09B05E7F-70A8-48B7-AA55-6D2F99B769A3 Q47941822-2DC0AA64-0C85-4AB1-87D8-576ED2D508BF Q47959144-FEF29D09-C27A-4DAF-BD62-BF24EDC046E4 Q51347358-DEE5BF59-5D11-4F75-B1A2-A1270184917B Q51407617-B02C5B7E-C053-4E52-873B-FCB01D4B8D6D Q53115803-7A305AA8-C498-40EE-A483-79D6B11A56BD Q53122101-CABBA269-A8DB-4C76-A0DB-E75A278703E0 Q53194326-FC476AEF-A083-4023-8FF3-804FF228D515 Q53245198-C63C2AC5-6050-4090-A81F-40A71637088D Q53261275-EC014C24-2C3F-4627-A5E7-8827FC9C648A

P2860

The role of 18F-FDG PET/CT in evaluation of early response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.

http://www.wikidata.org/entity/Q46123246

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

The role of 18F-FDG PET/CT in ...... ocally advanced breast cancer.

@en

The role of 18F-FDG PET/CT in ...... ocally advanced breast cancer.

@nl

type

label

The role of 18F-FDG PET/CT in ...... ocally advanced breast cancer.

@en

The role of 18F-FDG PET/CT in ...... ocally advanced breast cancer.

@nl

prefLabel

The role of 18F-FDG PET/CT in ...... ocally advanced breast cancer.

@en

The role of 18F-FDG PET/CT in ...... ocally advanced breast cancer.

@nl

P1433

Q46123246-1CB34322-C82F-4BD6-B9AE-9711115B4011

P1476

Q46123246-A78D3AAA-7F56-4ED1-A8D2-CF9D256D7D38

P2093

Q46123246-0EF0C63D-905F-4E62-A9E1-8999CA0FAF97

Q46123246-308E5ADC-BCB7-4014-987C-FC4ED6C0412C

Q46123246-4F65B278-75BF-4AB1-A04B-9A28DF8EE174

Q46123246-4FC749A6-7D15-446F-A69C-1B7686BDB79A

Q46123246-53AC026C-B7B3-430E-AB2D-F92F132EEB09

Q46123246-6672D194-FDFF-4868-8805-F2B341B23AAA

Q46123246-CE2A591B-B9B4-4C91-A623-8EBC7DE8FC08

P2888

Q46123246-907041C2-ADE4-4F00-B2E3-5B8099DCE857

P304

Q46123246-182436A1-1386-4415-A651-0D419DB2D1CF

P31

Q46123246-BA69C3B2-D4FE-4637-B91A-BAC665F67A71

P356

Q46123246-161A5A08-CA1E-4481-AD67-0A1B336D2987

P407

Q46123246-35C5991F-872A-40EA-8A5A-4F32CAB48A2B

P433

Q46123246-977454E8-0D38-4C05-8871-DF2C1B6A6EAB

P478

Q46123246-843DAEF2-F6CC-430A-88E0-D528A99A651D

P577

Q46123246-69DBCE7B-9096-4451-8052-8308FD0B70F3

P5875

Q46123246-C81CFCBB-B2A1-4D8D-B74A-6AE3C2C0A3C8

P698

Q46123246-0CBDBE2B-4593-44A1-A38A-18E3C509A500

P921

Q46123246-82DA66A5-4F94-4E7C-B1D6-91F1BDD855A4

P356

S00330-009-1303-Z

P1433

European Radiology

P1476

The role of 18F-FDG PET/CT in ...... ocally advanced breast cancer.

@en

P2093

Amandeep Kumar

http://www.w3.org/2001/XMLSchema#string

Arun Malhotra

http://www.w3.org/2001/XMLSchema#string

Madhavi Chawla

http://www.w3.org/2001/XMLSchema#string

Rakesh Kumar

http://www.w3.org/2001/XMLSchema#string

Sada Nand Mehta

http://www.w3.org/2001/XMLSchema#string

Sidharatha Datta Gupta

http://www.w3.org/2001/XMLSchema#string

Vathalaru Seenu

http://www.w3.org/2001/XMLSchema#string

P2888

s00330-009-1303-z

P304

1347-1357

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00330-009-1303-Z

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2009-02-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

226811046

http://www.w3.org/2001/XMLSchema#string

P698

19214522

http://www.w3.org/2001/XMLSchema#string

P921